Strata skin sciences secures additional $12 million financing with midcap financial

Horsham, pa., july 06, 2023 (globe newswire) -- strata skin sciences, inc. (nasdaq: sskn), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it has completed the refinancing of its existing debt agreement with a new facility from midcap financial (midcap). the new debt facility consists of a refinancing of the existing $8.0 million term loan and an additional $7.0 million tranche funded at closing. the company also has the option to receive an additional $5 million tranche in 2024.
SSKN Ratings Summary
SSKN Quant Ranking